Icon

VALCYTE (nda021304)- (EQ 450MG BASE)

VALGANCICLOVIR HYDROCHLORIDE CHEPLAPHARM
EQ 450MG BASE
Yes No
2015-Sep-29 Expired
None None
None No
VALCYTE is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for: *Adult Patients: • Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). • Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk. *Pediatric Patients: • Prevention of CMV disease in kidney and heart transplant patients at high risk.
9 0 7
Total Other Developers 1
Drugs with Suitability No
EQ 450MG BASE ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** ** ****** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** **** *** * ****** **** ******* *********** **** *, **. **.: ***, ***, *** & ***, ***** *********** ***, ********* *******, ************, ********* ******, ***** (***) ***
****** ** ****** **. *****'* ************ ******* *********** ***-*** - ******* **** - **, ****** ** ******,**,**&**, ****** ** * ** ** & ** ** **, **************** ******* ***********(*),, **********, ****** ******* ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ***** ******* *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. *-*, *-**, *-** *** *-**/*/*, ********** ********** ****, ******, *********** ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.